Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1. Issue 8 (August 2022)
- Record Type:
- Journal Article
- Title:
- Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1. Issue 8 (August 2022)
- Main Title:
- Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1
- Authors:
- Smart, Kelly
Zheng, Ming-Qiang
Ahmed, Hazem
Fang, Hanyi
Xu, Yuping
Cai, Lisheng
Holden, Daniel
Kapinos, Michael
Haider, Ahmed
Felchner, Zachary
Ropchan, Jim R
Tamagnan, Gilles
Innis, Robert B
Pike, Victor W
Ametamey, Simon M
Huang, Yiyun
Carson, Richard E - Abstract:
- The NMDA receptor GluN2B subunit is a target of interest in neuropsychiatric disorders but to date there is no selective radiotracer available to quantify its availability in vivo . Here we report direct comparisons in non-human primates of three GluN2B-targeting radioligands: (R) -[ 11 C]NR2B-Me, (R) -[ 18 F]OF-Me-NB1, and (S) -[ 18 F]OF-NB1. Plasma free fraction, metabolism, tissue distribution and kinetics, and quantitative kinetic modeling methods and parameters were evaluated in two adult rhesus macaques. Free fraction in plasma was <2% for (R) -[ 11 C]NR2B-Me and (R) -[ 18 F]OF-Me-NB1 and higher for (S) -[ 18 F]OF-NB1 (15%). All radiotracers showed good brain uptake and distribution throughout grey matter, with substantial (>68%) blockade across the brain by the GluN2B-targeting drug Co-101, 244 (0.25 mg/kg), including in the cerebellum. Time-activity curves were well-fitted by the one-tissue compartment model, with volume of distribution values of 20–40 mL/cm 3 for (R) -[ 11 C]NR2B-Me, 8–16 mL/cm 3 for (R) -[ 18 F]OF-Me-NB1, and 15–35 mL/cm 3 for (S) -[ 18 F]OF-NB1. Estimates of regional non-displaceable binding potential were in the range of 2–3 for (R) -[ 11 C]NR2B-Me and (S) -[ 18 F]-OF-NB1, and 0.5-1 for (R) -[ 18 F]OF-Me-NB1. Altogether, each radiotracer showed an acceptable profile for quantitative imaging of GluN2B. (S) -[ 18 F]OF-NB1 has particularly promising imaging characteristics for potential translation into humans. However, the source of unexpectedThe NMDA receptor GluN2B subunit is a target of interest in neuropsychiatric disorders but to date there is no selective radiotracer available to quantify its availability in vivo . Here we report direct comparisons in non-human primates of three GluN2B-targeting radioligands: (R) -[ 11 C]NR2B-Me, (R) -[ 18 F]OF-Me-NB1, and (S) -[ 18 F]OF-NB1. Plasma free fraction, metabolism, tissue distribution and kinetics, and quantitative kinetic modeling methods and parameters were evaluated in two adult rhesus macaques. Free fraction in plasma was <2% for (R) -[ 11 C]NR2B-Me and (R) -[ 18 F]OF-Me-NB1 and higher for (S) -[ 18 F]OF-NB1 (15%). All radiotracers showed good brain uptake and distribution throughout grey matter, with substantial (>68%) blockade across the brain by the GluN2B-targeting drug Co-101, 244 (0.25 mg/kg), including in the cerebellum. Time-activity curves were well-fitted by the one-tissue compartment model, with volume of distribution values of 20–40 mL/cm 3 for (R) -[ 11 C]NR2B-Me, 8–16 mL/cm 3 for (R) -[ 18 F]OF-Me-NB1, and 15–35 mL/cm 3 for (S) -[ 18 F]OF-NB1. Estimates of regional non-displaceable binding potential were in the range of 2–3 for (R) -[ 11 C]NR2B-Me and (S) -[ 18 F]-OF-NB1, and 0.5-1 for (R) -[ 18 F]OF-Me-NB1. Altogether, each radiotracer showed an acceptable profile for quantitative imaging of GluN2B. (S) -[ 18 F]OF-NB1 has particularly promising imaging characteristics for potential translation into humans. However, the source of unexpected displaceable binding in the cerebellum for each of these compounds requires further investigation. … (more)
- Is Part Of:
- Journal of cerebral blood flow & metabolism. Volume 42:Issue 8(2022)
- Journal:
- Journal of cerebral blood flow & metabolism
- Issue:
- Volume 42:Issue 8(2022)
- Issue Display:
- Volume 42, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 42
- Issue:
- 8
- Issue Sort Value:
- 2022-0042-0008-0000
- Page Start:
- 1398
- Page End:
- 1409
- Publication Date:
- 2022-08
- Subjects:
- Positron emission tomography -- glutamate -- NMDA receptor -- GluN2B subunit -- (S)-[18F]OF-NB1 -- (R)-[18F]OF-Me-NB1 -- (R)-[11C]NR2B-Me
Cerebral circulation -- Periodicals
Brain -- Metabolism -- Periodicals
Brain -- Blood-vessels -- Periodicals
Cerebrovascular disease -- Periodicals
612.824 - Journal URLs:
- http://jcb.sagepub.com/ ↗
http://136.142.56.160/ovidweb/ovidweb.cgi?T=JS&MODE=ovid&NEWS=N&PAGE=toc&D=ovid%5fovft&AN=00004647-000000000-00000 ↗
http://www.jcbfm.com ↗
http://www.nature.com/jcbfm/index.html ↗
http://www.nature.com/ ↗ - DOI:
- 10.1177/0271678X221084416 ↗
- Languages:
- English
- ISSNs:
- 0271-678X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.110000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21518.xml